Summary
Robbie Allen, CEO of One GI, Discusses AI, Provider Shortages, and Private Equity in GI Space
Introduction
Robbie Allen, the CEO of One GI, a gastroenterology endoscopy company that has been private equity funded, recently appeared on the Becker’s Healthcare Podcast to discuss the outlook for GI and what he sees in the private equity world.
Shifts in GI Industry
One of the biggest changes Allen sees is the shift away from procedural screening to liquid biopsy and genetic testing, thanks to advances in AI and other technologies. He also highlighted how provider shortages are affecting the GI industry.
Private Equity in GI
Allen also talked about the relationship between private equity and hospitals/health systems and how they need to work together to capture the full cascade of care in GI. He noted that there is still enormous interest in private equity investing in GI and healthcare overall, largely being driven by the dry powder sitting on the sidelines. However, Allen also commented on the gap between seller expectations and buyer expectations.
Closing Thoughts
In closing, Allen thanked the host for having him and expressed his enthusiasm for the future of the GI industry.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 01/01/2023 and can be listened here.
Subscribe to Beckers Healthcare Podcast here.
